On Invalid Date, Phio Pharmaceuticals (NASDAQ: PHIO) reported Q1 2023 earnings per share (EPS) of -$3.15, up 34.62% year over year. Total Phio Pharmaceuticals earnings for the quarter were -$3.60 million. In the same quarter last year, Phio Pharmaceuticals's earnings per share (EPS) was -$2.34.
As of Q2 2023, Phio Pharmaceuticals's earnings has grown year over year. Phio Pharmaceuticals's earnings in the past year totalled -$12.44 million.
What was PHIO's revenue last quarter?
On Invalid Date, Phio Pharmaceuticals (NASDAQ: PHIO) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Phio Pharmaceuticals's revenue was $0.00.
What was PHIO's revenue growth in the past year?
As of Q2 2023, Phio Pharmaceuticals's revenue has grown null year over year. Phio Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.